VIVO Cannabis Inc.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
OTC · IVITF · USD
Stock price, earnings
Quote as of May 27, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Invictus MD Strategies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Invictus MD Strategies Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Invictus MD Strategies Corp. is a Canadian firm primarily focused on strategic investments, acquisitions, and the development of complementary enterprises within the country's cannabis sector. The company's operations are divided into two main areas: cannabis sales and fertilizers. Its cannabis division is involved in the cultivation and distribution of medical cannabis. Concurrently, its fertilizer segment offers hydroponic plant fertilizers, nutrient solutions, and various other supplies essential for cultivation. Additionally, Invictus MD Strategies Corp. manages medical clinics situated in Alberta. The company was established in 2014 and maintains its principal office in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
A$0.02-A$0.00 (-4.76%)
Epsilon Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00+$0.00 (+14.94%)
China Infrastructure Construction Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.12+$0.00 (+2.52%)
Acreage Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.06% below the high.
$1.50$0.00 (0.0%)
Pixium Vision S.A.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.02+$0.00 (+6.19%)
Indiva Limited’s quoted price sits in the upper half of its reported 52-week range, 4.29% below the high.
$3.25+$0.03 (+0.93%)
Guardion Health Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.94% below the high.
$0.00+$0.00 (+40.0%)
Heritage Cannabis Holdings Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.